Ankit Mahadevia, CEO and President: Spero Therapeutics SPRO Sell · Filed 23/02/06

Trade details

Type: Insider sale
Amount: $22,237.66
Shares · price: 12,286 sh · $1.81 a share
Held after: 797,832 sh
Stock: Spero Therapeutics SPRO
Person: Ankit MahadeviaCEO and President
Trade date: 23/02/03
Filed: 23/02/06
Days to filing: 3 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Spero Therapeutics trades, last 26 weeks

What else happened in Spero Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/04~23/03/05

Ankit Mahadevia's recent trades

Ankit MahadeviaDirector
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$12.9K
6,572 sh
$12.9K
Filed 25/09/03
Traded 25/08/28
Ankit MahadeviaDirector
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$43.1K
55,260 sh
$43.1K
Filed 25/02/05
Traded 25/02/05
Ankit MahadeviaDirector
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$10.9K
13,959 sh
$10.9K
Filed 25/02/05
Traded 25/02/05
Ankit MahadeviaDirector
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$7,981
5,912 sh
$7,981
Filed 24/08/29
Traded 24/08/27
Ankit MahadeviaDirector
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$87.4K
63,795 sh
$87.4K
Filed 24/02/05
Traded 24/02/02